Related references
Note: Only part of the references are listed.Smoke Gets in the Eye: A systematic review of case reports of ocular complications of crack cocaine use
Hemant Gohil et al.
DRUG AND ALCOHOL REVIEW (2022)
Evolution of hospitalized patient characteristics through the first three COVID-19 waves in Paris area using machine learning analysis
Camille Jung et al.
PLOS ONE (2022)
Mechanism of Anosmia Caused by Symptoms of COVID-19 and Emerging Treatments
Raziyeh Najafloo et al.
ACS CHEMICAL NEUROSCIENCE (2021)
Immunological imprint of COVID-19 on human peripheral blood leukocyte populations
Bernhard Kratzer et al.
ALLERGY (2021)
Disease-Modifying Therapies and Coronavirus Disease 2019 Severity in Multiple Sclerosis
Maria P. Sormani et al.
ANNALS OF NEUROLOGY (2021)
Are smokers protected against SARS-CoV-2 infection (COVID-19)? The origins of the myth
Naomi A. van Westen-Lagerweij et al.
NPJ PRIMARY CARE RESPIRATORY MEDICINE (2021)
Lombardy, Northern Italy: COVID-19 second wave less severe and deadly than the first? A preliminary investigation
Andrea Borghesi et al.
INFECTIOUS DISEASES (2021)
COVID-19-Induced Anosmia and Ageusia Are Associated With Younger Age and Lower Blood Eosinophil Counts
Esha Sehanobish et al.
AMERICAN JOURNAL OF RHINOLOGY & ALLERGY (2021)
Predictive symptoms for COVID-19 in the community: REACT-1 study of over 1 million people
Joshua Elliott et al.
PLOS MEDICINE (2021)
Coronavirus disease 2019 in Latin American patients with multiple sclerosis
Yara D. Fragoso et al.
MULTIPLE SCLEROSIS AND RELATED DISORDERS (2021)
Post-acute COVID-19 syndrome
Ani Nalbandian et al.
NATURE MEDICINE (2021)
Multiple sclerosis and COVID-19: The Swedish experience
Anne-Marie Landtblom et al.
ACTA NEUROLOGICA SCANDINAVICA (2021)
First, second and third wave of COVID-19. What have we changed in the ICU management of these patients?
Manuel Taboada et al.
JOURNAL OF INFECTION (2021)
The outcome of a national MS-Covid-19 study: What the Turkish MS cohort reveals?
S. Sen et al.
MULTIPLE SCLEROSIS AND RELATED DISORDERS (2021)
COVID-19 Among Patients With Multiple Sclerosis A Systematic Review
Mahdi Barzegar et al.
NEUROLOGY-NEUROIMMUNOLOGY & NEUROINFLAMMATION (2021)
The effects of alcohol and illicit drug use on the skin
Neelesh P. Jain et al.
CLINICS IN DERMATOLOGY (2021)
Characteristics and Risk Factors of Hospitalized and Nonhospitalized COVID-19 Patients, Atlanta, Georgia, USA, March-April 2020
Kristen Pettrone et al.
EMERGING INFECTIOUS DISEASES (2021)
Active smoking is not associated with severity of coronavirus disease 2019 (COVID-19)
Giuseppe Lippi et al.
EUROPEAN JOURNAL OF INTERNAL MEDICINE (2020)
The impact of COPD and smoking history on the severity of COVID-19: A systemic review and meta-analysis
Qianwen Zhao et al.
JOURNAL OF MEDICAL VIROLOGY (2020)
Clinical Characteristics and Outcomes in Patients With Coronavirus Disease 2019 and Multiple Sclerosis
Celine Louapre et al.
JAMA NEUROLOGY (2020)
Clinical characteristics, management and in-hospital mortality of patients with coronavirus disease 2019 in Genoa, Italy
Antonio Vena et al.
CLINICAL MICROBIOLOGY AND INFECTION (2020)
COVID-19: A review of the proposed pharmacological treatments
Sarah Lam et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2020)
Sex differences in the frequency of gastrointestinal symptoms and olfactory or taste disorders in 1942 nonhospitalized patients with coronavirus disease 2019 (COVID-19)
Radoslaw Sierpinski et al.
POLISH ARCHIVES OF INTERNAL MEDICINE-POLSKIE ARCHIWUM MEDYCYNY WEWNETRZNEJ (2020)
Current smoking, former smoking, and adverse outcome among hospitalized COVID-19 patients: a systematic review and meta-analysis
Konstantinos Farsalinos et al.
THERAPEUTIC ADVANCES IN CHRONIC DISEASE (2020)
Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19 disease
Thomas Struyf et al.
COCHRANE DATABASE OF SYSTEMATIC REVIEWS (2020)
Efficacy and Safety of Delayed-release Dimethyl Fumarate for Relapsing-remitting Multiple Sclerosis in Prior Interferon Users: An Integrated Analysis of DEFINE and CONFIRM
Oscar Fernandez et al.
CLINICAL THERAPEUTICS (2017)
Disease-modifying therapies and infectious risks in multiple sclerosis
Alexander Winkelmann et al.
NATURE REVIEWS NEUROLOGY (2016)
Unawareness of Olfactory Dysfunction and its Association with Cognitive Functioning in Middle Aged and Old Adults
Eike Wehling et al.
ARCHIVES OF CLINICAL NEUROPSYCHOLOGY (2011)
Loss of smell (Anosmia) and taste (Ageusia) in a patient treated with pegylated interferon alfa and ribavirin
Ahmed Yacoob Mayet
CURRENT THERAPEUTIC RESEARCH-CLINICAL AND EXPERIMENTAL (2007)